Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.92 CAD
−7.37 M CAD
0.00 CAD
5.06 M
About BRIGHT MINDS BIOSCIENCES INC.
Sector
Industry
CEO
Ian B. McDonald
Website
Headquarters
New York
Founded
2019
FIGI
BBG00Z61F2X6
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in New York, NY.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of DRUG is 55.05 CAD — it has increased by 17.50% in the past 24 hours. Watch BRIGHT MINDS BIOSCIENCES INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange BRIGHT MINDS BIOSCIENCES INC. stocks are traded under the ticker DRUG.
DRUG stock has risen by 6.58% compared to the previous week, the month change is a −20.29% fall, over the last year BRIGHT MINDS BIOSCIENCES INC. has showed a 3.05 K% increase.
We've gathered analysts' opinions on BRIGHT MINDS BIOSCIENCES INC. future price: according to them, DRUG price has a max estimate of 75.00 CAD and a min estimate of 75.00 CAD. Watch DRUG chart and read a more detailed BRIGHT MINDS BIOSCIENCES INC. stock forecast: see what analysts think of BRIGHT MINDS BIOSCIENCES INC. and suggest that you do with its stocks.
DRUG reached its all-time high on Oct 18, 2024 with the price of 108.00 CAD, and its all-time low was 1.70 CAD and was reached on Nov 8, 2023. View more price dynamics on DRUG chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DRUG stock is 14.90% volatile and has beta coefficient of 77.80. Track BRIGHT MINDS BIOSCIENCES INC. stock price on the chart and check out the list of the most volatile stocks — is BRIGHT MINDS BIOSCIENCES INC. there?
Today BRIGHT MINDS BIOSCIENCES INC. has the market capitalization of 452.21 M, it has decreased by −10.76% over the last week.
Yes, you can track BRIGHT MINDS BIOSCIENCES INC. financials in yearly and quarterly reports right on TradingView.
BRIGHT MINDS BIOSCIENCES INC. is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
DRUG earnings for the last quarter are −0.60 CAD per share, whereas the estimation was −0.60 CAD resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.88 CAD per share. See more details about BRIGHT MINDS BIOSCIENCES INC. earnings.
DRUG net income for the last quarter is 229.90 K CAD, while the quarter before that showed −574.14 K CAD of net income which accounts for 140.04% change. Track more BRIGHT MINDS BIOSCIENCES INC. financial stats to get the full picture.
No, DRUG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 5, 2024, the company has 0.00 employees. See our rating of the largest employees — is BRIGHT MINDS BIOSCIENCES INC. on this list?
Like other stocks, DRUG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BRIGHT MINDS BIOSCIENCES INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BRIGHT MINDS BIOSCIENCES INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BRIGHT MINDS BIOSCIENCES INC. stock shows the buy signal. See more of BRIGHT MINDS BIOSCIENCES INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.